Navigation Links
Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): Phase III Data on Bayer's Investigational Compound Regorafenib (BAY 73-4506) in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Or
Date:1/10/2012

nimal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare Pharmaceuticals provides products for Diagnostic Imaging, General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases. 

BAYER (reg'd) and the Bayer Cross (reg'd) are trademarks of Bayer.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

References: 

(1).   A. Grothey, et al. Results of a phase III randomized, double-blind, multicenter trial (CORRECT) of regorafenib plus best supportive care (BSC) versus placebo plus BSC in patients with metastatic colorectal cancer (mCRC) who have progressed after standard therapies [Abstract]. 2012 Gastrointestinal Cancers Symposium; January 19-21, 2012. San Francisco, CA.


'/>"/>
SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
2. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
3. New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy
4. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
5. Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
6. Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use
7. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
8. New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors
9. Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
10. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
11. OPAXIO(TM) Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore e pioniere ... respiratori del sonno (SDB) e altre patologie croniche del ... il produttore Taiwanese di dispositivi medicali, APEX Medical Corp. ... in testa, che violano i brevetti, utilizzate con l,APEX ... Corte Regionale Distrettuale di Monaco , ...
(Date:7/28/2014)... 28, 2014  ResMed (NYSE: RMD ), ... treatment of sleep-disordered breathing and other chronic respiratory conditions, ... against Taiwanese medical device manufacturer APEX Medical ... APEX WiZARD 210 and 220 masks.  The judgment was ... Munich , is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... England , July 28, 2014 /PRNewswire/ ... dass Albion Ventures 2,5 Millionen £ investiert ... in der Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche ... Ventures.      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ... 18 Monaten hat OmPrompt sein beschleunigtes Wachstum ...
Breaking Medicine Technology:ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 Launched in ... Heaven surpassed 20,000 hangovers earlier this year at ... prepares for expansion and the publication of research data ... the medical practice. , The only licensed medical practice ... Hangover Heaven launched in 2012 and treated thousands of ...
(Date:7/29/2014)... brides want their bridal dresses and bridal parties to ... sure to provide designs of wedding gowns and bridesmaids ... has recently announced its new collection of gorgeous lace ... come with big savings, up to 61% off. , ... working in the garment industry for several years; they ...
(Date:7/28/2014)... are gluttons. We have long known that they monopolize ... that some tumor cells are also characterized by a ... join in an ordered set. Researchers are calling this ... At EPFL, Etienne Meylan,s research team was able to ... and mesenchymal behavior result from the same mechanism, ...
(Date:7/28/2014)... “China Surgical Generators Market Outlook to ... Surgical Generators market. The report provides value, in ... average prices (in US dollars) within market segments ... Argon Plasma Coagulation Generators. , The report also ... each of these market categories, and global corporate-level ...
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading ... the release of the fourth edition of The Brain ... Underwood. , The Brain Health Guide is a unique ... readers to improve memory and promote optimal aging. Rather ... Health Guide provides ways to help minimize common memory ...
Breaking Medicine News(10 mins):Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3Health News:LunaDress’ Summer Sale Has Arrived: All Its Gorgeous Lace Wedding Dresses are Affordable Now 2Health News:Cancer: Tumors absorb sugar for mobility 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 2Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 3Health News:Key Market Data on China Surgical Generators Market to 2020 Report Available at MarketOptimizer.org 4Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2
... ... We are pleased to announce the launch of Anianet, a free ... the Chinese academic market has continued to explode (there are now ... three times more engineering PH.D.,s annually than the United States), China,s ...
... ... http://www.youmeandtea.com , ... NY (PRWEB) -- You, Me and Tea is pleased to announce the launch of their new ... India, China, and Sri Lanka and specializes in the retailing of India,s world-renowned teas (Darjeeling, Assam ...
... ... Follicular Unit Extraction (FUE) hair restoration office using NeoGraft™. Automated FUE ... does not require scalpels, sutures, staples, and leaves no scars on the ... brings to Orange County and Southern California, a fully equipped and trained ...
... Quality ... ... Associates, Inc. today announced a broad partnership with Health Management Associates , Inc. (NYSE:HMA) ... started working with HMA on October 1, 2009. , , , , ,HMA owns and ...
... 15 As the 2010 Dietary Guidelines for ... sodium consumption are being considered, an analysis of evidence ... the American Society of Nephrology (CJASN) questions the ... limit salt intake in humans. , After examining ...
... The 2009 Cumulative Supplement to ... legal developments in pharmaceutical patent law. Published by ... , Pharmaceutical Patent Law is supplemented annually ... implications of patent settlements; the experimental use privilege; and international ...
Cached Medicine News:Health News:New Professional Network Brings Chinese Scientists and Researchers into International Community 2Health News:New Professional Network Brings Chinese Scientists and Researchers into International Community 3Health News:New Professional Network Brings Chinese Scientists and Researchers into International Community 4Health News:You, Me and Tea is Pleased to Announce the Website Debut of youmeandtea.com 2Health News:New NeoGraft Hair Restoration Now Available in Orange County, California 2Health News:New NeoGraft Hair Restoration Now Available in Orange County, California 3Health News:New NeoGraft Hair Restoration Now Available in Orange County, California 4Health News:Press Ganey Partners With Health Management Associates 2Health News:New Evidence Shakes Up Perceptions of Salt 2Health News:New Evidence Shakes Up Perceptions of Salt 3Health News:New Evidence Shakes Up Perceptions of Salt 4Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 2Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: